Your Testing of SoapAI?
Steven Charlap, MD, MBA
To save the lives of millions of people I will never meet!
Dear LinkedIn Connections
I hope you have all done well over the past year.
I am writing today about a project I have been working on for the past several years.
Seven years ago, one of my older brothers, Shlomo, a practicing cardiologist, was diagnosed with two primary cancers, a week apart. He passed away 13 months later Z’L.
I know, as a physician, that part of the fault of his death was that no doctor ever told him that his family history of cancer, nor mine for that matter, was a big red flag that required constant surveillance. It would have both required collecting and interpreting a detailed family history. Typically, that does not happen for multiple reasons including time constraints and knowledge gaps. If my brother had received such surveillance, I believe he would still be alive today. It turned out he had a genetic mutation most likely responsible for the cancer. I don’t, but again, no doctor has ever discussed it with me. Nor my extensive family history of heart disease and diabetes. Every doctor that collects any family hsitory seems to stop with parents and siblings; yet, in my case the real story is with my uncles, aunts, and first cousins. Yes, the evidence shows they really, really matter.
At the time of Shlomo’s passing, I was running my second startup focused on preventive medicine. A month after his passing, I closed the business and ended up at Stanford for three years studying genetics and genomics, getting involved in a published genomics research study, and then getting a grant to build an early prototype of the software I am writing about today.
Almost three months ago, my team finished SoapAI?. SoapAI? is an AI-powered artificial human driven software that collects a detailed personal and family medical history and then identifies based on 9 sets of medical association guidelines whether the user is at increased risk for cancer, heart disease, and type 2 diabetes, and also identifies recommendations for genetic testing and other diagnostic procedures to further evaluate your risk. We are doing a pilot at Stanford in late January.
Before the pilot, we are extensively testing the software. I am offering no charge access to the software to the first 25 among you that are willing to complete the program and provide feedback on its usability, usefulness, etc. The deadline is January 1, 2021.
Please write me at [email protected] if you are interested in identifying your and/or your loved one’s risks. This is the most advanced risk assessment tool ever created. I have already spent over $750,00 on it. However, it is not a replacement for your physician and you should not solely rely on the results you will get. This software is meant to be used in conjunction with you consulting other family members to complete it because it collects an in-depth history including a three generation family history.
I look forward to hearing from twenty-five of you.
To your health,
Steven Charlap